Literature DB >> 10214982

Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses in rats.

D E Dluzen1, S Muraoka, R Landgraf.   

Abstract

Male rats were implanted bilaterally with cannulae directed at the olfactory bulbs and infused with either vehicle or 6-OHDA to selectively deplete norepinephrine concentrations at this site. At 5-7 days following this treatment, these animals received a bilateral infusion of either arginine vasopressin (AVP) or oxytocin (OXT) through these same guide cannulae and were then tested for their capacity to maintain social recognition responses. Neither infusion of AVP nor OXT were able to preserve recognition responses in the animals treated with 6-OHDA. In contrast, comparably tested animals who received a vehicle infusion showed clear recognition responses following either the AVP or OXT infusion. These results suggest that this capacity for these neuropeptides to preserve social recognition responses is mediated through the norepinephrine system of the olfactory bulb.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10214982     DOI: 10.1016/s0304-3940(98)00691-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

Review 1.  Oxytocin, vasopressin and pair bonding: implications for autism.

Authors:  Elizabeth A D Hammock; Larry J Young
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

Review 2.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

3.  Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.

Authors:  Gregory P Strauss; William R Keller; James I Koenig; James M Gold; Kathryn L Ossenfort; Robert W Buchanan
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

Review 4.  From adolescence to late aging: A comprehensive review of social behavior, alcohol, and neuroinflammation across the lifespan.

Authors:  Amy E Perkins; Elena I Varlinskaya; Terrence Deak
Journal:  Int Rev Neurobiol       Date:  2019-08-24       Impact factor: 3.230

5.  Oxytocin in the medial amygdala is essential for social recognition in the mouse.

Authors:  J N Ferguson; J M Aldag; T R Insel; L J Young
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

6.  Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Argelia Esperanza Rojas-Mayorquin; Claudia P Figueiredo; Filipe C Matheus; Laure Ginestet; Caroline Chevarin; Elaine Del Bel; Raymond Mongeau; Michel Hamon; Laurence Lanfumey; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

7.  Effects of multiparity on recognition memory, monoaminergic neurotransmitters, and brain-derived neurotrophic factor (BDNF).

Authors:  Abbe H Macbeth; Helen E Scharfman; Neil J Maclusky; Claris Gautreaux; Victoria N Luine
Journal:  Horm Behav       Date:  2007-08-31       Impact factor: 3.587

Review 8.  Oxytocin: the great facilitator of life.

Authors:  Heon-Jin Lee; Abbe H Macbeth; Jerome H Pagani; W Scott Young
Journal:  Prog Neurobiol       Date:  2009-04-10       Impact factor: 11.685

Review 9.  Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior.

Authors:  Heather E Ross; Larry J Young
Journal:  Front Neuroendocrinol       Date:  2009-05-28       Impact factor: 8.606

Review 10.  Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia.

Authors:  Christina A Wilson; James I Koenig
Journal:  Eur Neuropsychopharmacol       Date:  2013-11-26       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.